Target intelligence / Profile preview

Potassium channel subfamily K member 7 (KCNK7)

Target
KCNK7
Molecular classification
Ion channel, Two-pore-domain potassium channel (K2P family), Transmembrane protein
01

Overview

Potassium channel subfamily K member 7 (KCNK7) is a human gene encoding a member of the two-pore-domain potassium channel (K2P) family[1][2][3][4]. It is characterized by two pore-forming domains and four transmembrane segments typical of K2P channels. Unlike other functional K2P channels, KCNK7 has not been shown to function as an active channel by itself in heterologous expression systems, likely remaining in the endoplasmic reticulum and potentially requiring association with unknown partners to reach the plasma membrane and mediate potassium flux[1][2][6]. Its physiological roles are inferred from genetic studies, transcriptomic analyses, and related pathways, suggesting involvement in regulating cellular excitability, apoptosis, adrenal gland function, and neuronal processes. KCNK7 has been implicated in some disease associations—such as adrenal cortical adenocarcinoma, Birk-Barel syndrome, and has been found upregulated in atrial fibrillation[1][2]. Despite its classification as a potassium channel, the precise biological mechanisms, interacting drugs, and suitability as a therapeutic target remain largely unexplored due to the lack of confirmed channel activity and unknown molecular partners[1][2][4][6].

Other names
K2P7.1TWIK3potassium two pore domain channel subfamily K member 7potassium channel, two pore domain subfamily K, member 7two pore domain K+ channel
02

Biological functions

Potassium ion leak channel activityRegulation of membrane potentialOpposes membrane depolarizationRegulation of cellular excitabilityInvolvement in apoptosisPotential role in neuronal excitabilityPossible involvement in adrenal gland development and hyperaldosteronism
03

Disease associations

Adrenal cortical adenocarcinomaAtrial fibrillation (gene up-regulated in AF)Birk-Barel syndromePossible roles in other disorders linked to chromosome 11q13
04

Safety considerations

Nonfunctional alone; may require cofactors or partners, complicating modulation[1][2][6]Unclear physiological significance due to lack of observed channel activity in heterologous systemsUnknown safety profile for therapeutic targeting
05

Biomarkers

Changes in KCNK7 mRNA may serve as a biomarker in atrial fibrillation and possibly other related disease states[1][2]

Beyond the preview

Go deeper on Potassium channel subfamily K member 7 (KCNK7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel subfamily K member 7 (KCNK7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call